In addition, the CSF p‐Tau levels in the rpAD group were higher than that of the AE, CJD, and CN groups (p < 0.001), while the serum p‐Tau levels in the CJD group were higher than that of the other three groups (p < 0.01). The gene discussed is MAPT; the disease is Creutzfeldt Jacob disease.